These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ. Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791 [Abstract] [Full Text] [Related]
25. The effects of telmisartan alone or with hydrochlorothiazide on morning and 24-h ambulatory BP control: results from a practice-based study (SURGE 2). Parati G, Bilo G, Redon J, SURGE Steering Committee. Hypertens Res; 2013 Apr; 36(4):322-7. PubMed ID: 23154590 [Abstract] [Full Text] [Related]
32. Cardiovascular outcomes in the first trial of antihypertensive therapy guided by self-measured home blood pressure. Asayama K, Ohkubo T, Metoki H, Obara T, Inoue R, Kikuya M, Thijs L, Staessen JA, Imai Y, Hypertension Objective Treatment Based on Measurement by Electrical Devices of Blood Pressure (HOMED-BP). Hypertens Res; 2012 Nov; 35(11):1102-10. PubMed ID: 22895063 [Abstract] [Full Text] [Related]
36. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study. Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL. Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367 [Abstract] [Full Text] [Related]